152 related articles for article (PubMed ID: 36155871)
1. Clinical characteristics of SLE patients infected with Epstein-Barr virus and potential associated risk factors.
Ming B; Bai M; Cai S; Wang B; Zhong J; Dong L
Clin Rheumatol; 2023 Jan; 42(1):101-109. PubMed ID: 36155871
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
[TBL] [Abstract][Full Text] [Related]
4. Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan.
Yu SF; Wu HC; Tsai WC; Yen JH; Chiang W; Yuo CY; Lu SN; Chiang LC; Chen CJ
Med Microbiol Immunol; 2005 May; 194(3):115-20. PubMed ID: 15378356
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus.
Banko A; Cirkovic A; Miskovic R; Jeremic I; Grk M; Basaric M; Lazarevic I; Raskovic S; Despotovic A; Miljanovic D
Front Immunol; 2023; 14():1307589. PubMed ID: 38146370
[TBL] [Abstract][Full Text] [Related]
6. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
[TBL] [Abstract][Full Text] [Related]
7. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan.
Lu JJ; Chen DY; Hsieh CW; Lan JL; Lin FJ; Lin SH
Lupus; 2007; 16(3):168-75. PubMed ID: 17432101
[TBL] [Abstract][Full Text] [Related]
8. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies.
Laurynenka V; Ding L; Kaufman KM; James JA; Harley JB
Front Immunol; 2022; 13():830993. PubMed ID: 35251022
[TBL] [Abstract][Full Text] [Related]
9. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
[TBL] [Abstract][Full Text] [Related]
10. INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS.
Guta S; Abrahamovych O; Abrahamovych U; Tsyhanyk L; Farmaha M
Georgian Med News; 2023 May; (338):121-125. PubMed ID: 37419485
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of the Epstein-Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil.
França SAS; Viana JBGO; Góes HCA; Fonseca RRS; Laurentino RV; Costa IB; Oliveira-Filho AB; Machado LFA
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458425
[TBL] [Abstract][Full Text] [Related]
12. Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus.
Chen X; Li H; Wu C; Zhang Y
Virol J; 2023 Feb; 20(1):29. PubMed ID: 36782252
[TBL] [Abstract][Full Text] [Related]
13. A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus.
Chen M; Tu J; Huang M; Cheng Y; Sun L
Clin Rheumatol; 2024 May; 43(5):1521-1530. PubMed ID: 38509241
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
15. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.
Parks CG; Cooper GS; Hudson LL; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS; Pandey JP
Arthritis Rheum; 2005 Apr; 52(4):1148-59. PubMed ID: 15818712
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.
James JA; Neas BR; Moser KL; Hall T; Bruner GR; Sestak AL; Harley JB
Arthritis Rheum; 2001 May; 44(5):1122-6. PubMed ID: 11352244
[TBL] [Abstract][Full Text] [Related]
17. Association of Human Leucocyte Antigen Class II, with viral load and immune response to Epstein-Barr virus in adult and pediatric Systemic lupus erythematosus patients.
Das P; Minz RW; Saikia B; Sharma A; Anand S; Singh H; Singh S
Lupus; 2022 Aug; 31(9):1054-1066. PubMed ID: 35607991
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus reactivation and disease flare of systemic lupus erythematosus.
Chen CJ
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):161-164. PubMed ID: 38485308
[TBL] [Abstract][Full Text] [Related]
19. The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis.
Li ZX; Zeng S; Wu HX; Zhou Y
Clin Exp Med; 2019 Feb; 19(1):23-36. PubMed ID: 30361847
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement.
Miskovic R; Cirkovic A; Miljanovic D; Jeremic I; Grk M; Basaric M; Lazarevic I; Stojanovic M; Plavsic A; Raskovic S; Banko A
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
